Komori
Lifedrink Company (2585) · InitiativeRaisedLatest Financial results presentation (2026-08-13): "Advanced"

Expanding Production Output by Improving Factory Utilization and Investing in Equipment

First written in FY2022-Q3. 11 of 19 entries say "Advanced", first in FY2022. Latest entry: 2026-08-13.

19entries
5years
5from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2023 – 2026-08-132022: 420222023: 420232024: 320242025: 220252026: 62026
Same theme, other companies
Expansion and Rationalization of Production FacilitiesA theme 377 companies write about · 0 as a headwind · 416 as a tailwind

126 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 182 companies compared. The sentences above are computed from all 182.Comparing 200 of the theme's 416 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RaisedAnnual report

    「Through these initiatives, we aim to establish a production system capable of producing 100 million cases* in the fiscal year ending March 2027 (120% of the fiscal year ended March 2026; excluding 生駒名水株式会社).」

    The production target for the fiscal year ending March 2027 was raised from the previous target of 84 million cases for the fiscal year ending March 2026 to 100 million cases. Plant updates, increased staffing, additional lines, new plant construction and M&A were cited as measures.
  2. FY2026-H1AdvancedAnnual report

    「We worked to expand production volume and secure sales outlets by acquiring production capacity through M&A.」

    While continuing to expand production volume through the acquisition of production capacity via M&A, the company spent ¥5,459 million on the acquisition of property, plant and equipment, and construction in progress also increased by ¥1,220 million. No new production results or plant-completion information was stated, but investment related to production capacity expansion is progressing.
  3. FY2025RaisedAnnual report

    「We will continue working to further advance and deepen “Max Production Max Sales” for our own beverages by increasing production capacity through updates and improvements at the group’s beverage plants, bringing plants to full production by strengthening staffing, adding lines at existing plants, constructing new plants, and acquiring production capacity through M&A. Through these initiatives, we aim to establish a production system capable of producing 84 million cases* in the fiscal year ending March 2026, 115% of the fiscal year ending March 2025, excluding 生駒名水株式会社.」

    The production target for the fiscal year ending March 2026 was raised from the previous 77 million cases to 84 million cases. Measures toward full production were expanded to include increased staffing, additional lines at existing plants, new plant construction and M&A.
  4. FY2025-H1AdvancedAnnual report

    「Expanding production volume, centered on efforts to bring the Gotemba Plant to full production at an early stage」

    Specific measures to expand production volume, centered on bringing the Gotemba Plant to full production at an early stage, were presented. Machinery and equipment and vehicles under property, plant and equipment increased by ¥4,994 million, while construction in progress decreased by ¥4,115 million, indicating that the facilities had progressed from the construction stage to the operational production stage.
  5. FY2024RaisedAnnual report

    「We will continue working to further advance and deepen “Max Production Max Sales” for our own beverages by increasing production capacity through updates and improvements at our beverage plants, raising plant utilization through improvement activities, strengthening production capacity through new plant construction, and acquiring production capacity through M&A. Through these initiatives, we aim to establish a production system capable of producing 77 million cases* in the fiscal year ending March 2026, 120% of the fiscal year ending March 2024, excluding 生駒名水株式会社.」

    The production target for the fiscal year ending March 2026 was raised from the previous 76 million cases to 77 million cases. Plant updates, higher utilization, new plant construction and M&A were cited as measures, and the Gotemba Plant was completed in March 2024.
  6. FY2024-Q3AdvancedAnnual report

    「Fixed assets at the end of the third quarter of the current consolidated fiscal year totaled ¥14,617 million, an increase of ¥3,357 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥1,388 million in land and ¥2,783 million in construction in progress.」

    For fixed assets apparently related to the construction of a new plant and equipment acquisition, construction in progress increased by ¥2,783 million from the end of the previous consolidated fiscal year, indicating further progress in capital investment.
  7. FY2024-Q2AdvancedAnnual report

    「Fixed assets at the end of the second quarter of the current consolidated fiscal year totaled ¥14,638 million, an increase of ¥3,377 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥2,440 million in construction in progress and ¥1,388 million in land.」

    In connection with capital investment to expand production capacity, fixed assets increased by ¥3,377 million from the end of the previous consolidated fiscal year, including increases of ¥2,440 million in construction in progress and ¥1,388 million in land. Investing activities included ¥3,212 million spent on the acquisition of property, plant and equipment, indicating progress in capital investment and new plant construction at both the capitalization and expenditure stages.
  8. FY2024-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 25 April 2023, the company resolved to borrow funds to finance the construction of a new plant and the acquisition of equipment, and entered into an agreement relating to the borrowing on the same date.」

    A ¥8,200 million commitment-type term loan agreement was executed to finance the construction of a new plant and the acquisition of equipment. Construction in progress under property, plant and equipment also increased by ¥1,220 million from the end of the previous consolidated fiscal year, indicating that the production capacity expansion plan had progressed to the financing and construction-preparation stage.
  9. FY2023RaisedAnnual report

    「We will continue working to further advance and deepen “Max Production Max Sales” for our own beverages by increasing production capacity through updates and improvements at our beverage plants, raising plant utilization through improvement activities, constructing new plants to increase production capacity, and acquiring production capacity through M&A. Through these initiatives, we aim to establish a production system capable of producing 76 million cases* in the fiscal year ending March 2026, the final year of our medium-term management plan, approximately 134% of the fiscal year ending March 2023, excluding 生駒名水株式会社.」

    Compared with the previous plan for 57 million cases in the fiscal year ending March 2024, actual production in the fiscal year ending March 2023 reached 57 million cases, and the target was further raised to 76 million cases in the fiscal year ending March 2026, approximately 134% of fiscal 2023 production. The measures of plant upgrades, higher utilization, new plant construction and M&A were also specified.
  10. FY2023-Q3RestatedAnnual report

    「Increasing production volume through updates and improvements at the company’s beverage plants」

    Measures to expand production volume through plant updates and improvements continue to be stated, but no new production results or milestones for completion of the facilities are presented.
  11. FY2023-Q2AdvancedAnnual report

    「Through this acquisition of shares, we aim to expand production volume across the group, broaden our product lineup by leveraging ニットービバレッジ’s product development capabilities, and increase production capacity by utilizing its abundant water sources, thereby achieving revenue growth and profit growth exceeding it.」

    In addition to expanding production volume through plant updates and improvements, expansion of production volume and capacity was made more concrete through the agreement to make ニットービバレッジ a subsidiary. However, the scheduled acquisition date is 4 January 2023, and the capacity expansion itself has not been completed.
  12. FY2023-Q1RestatedAnnual report

    「Increasing production volume through updates and improvements at the company’s beverage plants」

    Measures to expand production volume through plant updates and improvements continue to be stated, but no new production results or completed milestones are presented.
  13. FY2022AdvancedAnnual report

    「Production at our own plants in the fiscal year under review was 50 million cases, up 11.1% from the previous fiscal year. We aim to establish a production system capable of producing 57 million cases in the fiscal year ending March 2024, the final year of our medium-term management plan, by continuing to update and improve our beverage plants, constructing new plants, and acquiring production capacity through M&A.」

    Production at the company’s own plants reached 50 million cases, up 11.1% from the previous fiscal year. The company also presented a plan to produce 57 million cases in the fiscal year ending March 2024, with specific measures to expand production capacity through new plants, plant upgrades and M&A.
  14. FY2022-Q3First statedAnnual report

    「Increasing production volume through higher utilization of the company’s beverage plants and capital investment」

    Higher plant utilization and capital investment are described as specific measures to expand production volume.
Moved together

"Growth and Improved Profitability of the Company's Beverage Business and Maximization of Corporate and Shareholder Value" moved the same way as this thread, in the same document, in 13 of its 19 moves.

131110998★123456
  1. ★This thread
  2. 1Growth and Improved Profitability of the Company's Beverage Business and Maximization of Corporate and Shareholder Value13×
  3. 2Securing Customers and Expanding Beverage Sales11×
  4. 3Stable dividends targeting a 20% payout ratio while prioritizing retained earnings10×
  5. 4Strengthening Direct Sales Through E-Commerce Channels9×
  6. 5M&A to Acquire Production Capacity and Commercial and Logistics Functions9×
  7. 6EBITDA-Linked Compensation and Restricted Stock Compensation8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Lifedrink Company yet. It last moved in the Financial results presentation of 2026-08-13: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expanding Production Output by Improving Factory Utilization and Investing in Equipment | LIFEDRINK COMPANY,INC. (2585) | Komori